Healthcare -
Biotechnology - NASDAQ - GB
$ 51.89
-3.26 %
$ 4.25 B
Market Cap
-25.94
P/E
VRNA - COST OF REVENUE
Cost of Revenue VRNA - Verona Pharma plc
680 K
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR